检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘小利[1] 程胜[1] 黄艳君[1] 周洁[1] 黄引平[1] 熊春秋[1]
机构地区:[1]温州医学院附属第一医院,浙江温州325000
出 处:《中华中医药学刊》2009年第2期402-405,共4页Chinese Archives of Traditional Chinese Medicine
摘 要:目的:观察青心酮对内皮祖细胞的影响。方法:采用密度梯度离心法从脐血中获取单个核细胞,将其接种在人纤维连接蛋白包被培养板,培养7天后,收集贴壁细胞,加入不同浓度青心酮(分别为10-4、10-5、10-6mol/L)培养一定的时间(6、12、24、48,72 h)。通过激光共聚焦显微镜鉴定FITC-UEA-I和DiI-acLDL双染色阳性细胞被认为是正在分化的EPCs。然后分别采用MTT比色法、改良的Boyden小室、黏附能力测定实验观察EPCs的增殖能力、迁移能力及黏附能力。结果:青心酮显著增加EPCs集落形成数,并且EPCs集落形成数随青心酮浓度增加及作用时间延长而增加,10-4mol/L浓度青心酮作用72h对EPCs数量的影响最为显著。青心酮也显著改善了脐血EPCs的黏附能力、迁移能力和增殖能力。结论:结果提示青心酮可增加EPCs的数量且伴随着EPCs功能的改善。Objective:To investigate the effect of 3,4-Dihydroxyacetophenone on endothelial progenitor cells.Methods:EPCs were isolated from human umbilical cord blood.Cytochemical analysis was conducted after culture for 7 days.EPCs were characterized as that DiI-acLDL/FITC-UEA-I doublepositive cells were detected by laser confocalmicroscopy.These cells were Separated into 4 groups randomly:①control group:EPCs were suspended in endothelial cell basal medium(M199)supplemented with 20% fetal calf serum;②three groups with different concentration of 3,4-dihydroxyacetophenone:EPCs were suspended in M199 supplemented with10-4,10-5,10-6mol/L 3,4-Dihydroxyacetophenone,respectively.All groups were intervented for6,12,24,48 and 72hours,To compare the number of CFU,adhesion,migration and proliferation capability of EPCs.Results:10-4mol/L 3,4-Dihydroxyacetophenone markedly increase number of CFU,migration,adhesion and proliferation capability of EPCs with time accrescence,and it display time dependence.These parameters reach the peak at 72 hours.Conclusion:3,4-dihydroxyacetophenone may promote the repair of the damaged blood vessel endothelium and vasculogenesis through effecting the quantity,migration adhesion and proliferation capability of EPCs.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.145